389 related articles for article (PubMed ID: 16841094)
1. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.
Hafner C; van Oers JM; Vogt T; Landthaler M; Stoehr R; Blaszyk H; Hofstaedter F; Zwarthoff EC; Hartmann A
J Clin Invest; 2006 Aug; 116(8):2201-2207. PubMed ID: 16841094
[TBL] [Abstract][Full Text] [Related]
2. Keratinocytic epidermal nevi are associated with mosaic RAS mutations.
Hafner C; Toll A; Gantner S; Mauerer A; Lurkin I; Acquadro F; Fernández-Casado A; Zwarthoff EC; Dietmaier W; Baselga E; Parera E; Vicente A; Casanova A; Cigudosa J; Mentzel T; Pujol RM; Landthaler M; Real FX
J Med Genet; 2012 Apr; 49(4):249-53. PubMed ID: 22499344
[TBL] [Abstract][Full Text] [Related]
3. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
Logié A; Dunois-Lardé C; Rosty C; Levrel O; Blanche M; Ribeiro A; Gasc JM; Jorcano J; Werner S; Sastre-Garau X; Thiery JP; Radvanyi F
Hum Mol Genet; 2005 May; 14(9):1153-60. PubMed ID: 15772091
[TBL] [Abstract][Full Text] [Related]
4. Systemic epidermal nevus with involvement of the oral mucosa due to FGFR3 mutation.
Bygum A; Fagerberg CR; Clemmensen OJ; Fiebig B; Hafner C
BMC Med Genet; 2011 Jun; 12():79. PubMed ID: 21639936
[TBL] [Abstract][Full Text] [Related]
5. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.
Blomberg M; Jeppesen EM; Skovby F; Benfeldt E
Dermatology; 2010; 220(4):297-305. PubMed ID: 20453470
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors.
Hernández S; Toll A; Baselga E; Ribé A; Azua-Romeo J; Pujol RM; Real FX
J Invest Dermatol; 2007 Jul; 127(7):1664-6. PubMed ID: 17255960
[TBL] [Abstract][Full Text] [Related]
7. High frequency of FGFR3 mutations in adenoid seborrheic keratoses.
Hafner C; van Oers JM; Hartmann A; Landthaler M; Stoehr R; Blaszyk H; Hofstaedter F; Zwarthoff EC; Vogt T
J Invest Dermatol; 2006 Nov; 126(11):2404-7. PubMed ID: 16778799
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor 3 (FGFR3) mutation in a verrucous epidermal naevus associated with mild facial dysmorphism.
Collin B; Taylor IB; Wilkie AO; Moss C
Br J Dermatol; 2007 Jun; 156(6):1353-6. PubMed ID: 17441958
[TBL] [Abstract][Full Text] [Related]
9. [Nevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal nevus): three cases].
Petit A; Lemarchand-Venencie F; Pinquier L; Lebbe C; Bourrat E
Ann Dermatol Venereol; 2012 Mar; 139(3):183-8. PubMed ID: 22401682
[TBL] [Abstract][Full Text] [Related]
10. Incidence of fibroblast growth factor receptor 3 gene (FGFR3) A248C, S249C, G372C, and T375C mutations in bladder cancer.
Dodurga Y; Tataroglu C; Kesen Z; Satiroglu-Tufan NL
Genet Mol Res; 2011 Jan; 10(1):86-95. PubMed ID: 21264819
[TBL] [Abstract][Full Text] [Related]
11. An epidermal nevus syndrome with cerebral involvement caused by a mosaic FGFR3 mutation.
García-Vargas A; Hafner C; Pérez-Rodríguez AG; Rodríguez-Rojas LX; González-Esqueda P; Stoehr R; Hernández-Torres M; Happle R
Am J Med Genet A; 2008 Sep; 146A(17):2275-9. PubMed ID: 18642369
[TBL] [Abstract][Full Text] [Related]
12. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
13. FGFR3 mutations in epidermal nevi and seborrheic keratoses: lessons from urothelium and skin.
Hafner C; Hartmann A; Vogt T
J Invest Dermatol; 2007 Jul; 127(7):1572-3. PubMed ID: 17568799
[TBL] [Abstract][Full Text] [Related]
14. Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders.
van Rhijn BW; van Tilborg AA; Lurkin I; Bonaventure J; de Vries A; Thiery JP; van der Kwast TH; Zwarthoff EC; Radvanyi F
Eur J Hum Genet; 2002 Dec; 10(12):819-24. PubMed ID: 12461689
[TBL] [Abstract][Full Text] [Related]
15. Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.
Hafner C; Vogt T; Landthaler M; Müsebeck J
Br J Dermatol; 2008 Jul; 159(1):214-7. PubMed ID: 18503601
[TBL] [Abstract][Full Text] [Related]
16. Topical sirolimus therapy for epidermal nevus with features of acanthosis nigricans.
Dodds M; Maguiness S
Pediatr Dermatol; 2019 Jul; 36(4):554-555. PubMed ID: 30983034
[TBL] [Abstract][Full Text] [Related]
17. Mosaic mutations in FGFR3 and FGFR2 are associated with naevoid acanthosis nigricans or RAVEN (round and velvety epidermal naevus).
Larsabal M; Cogrel O; Caumont C; Jegou MH; Taïeb A; Morice-Picard F
Br J Dermatol; 2019 Jan; 180(1):201-202. PubMed ID: 30117157
[No Abstract] [Full Text] [Related]
18. Familial systematized epidermal nevus syndrome.
Meschia JF; Junkins E; Hofman KJ
Am J Med Genet; 1992 Nov; 44(5):664-7. PubMed ID: 1481830
[TBL] [Abstract][Full Text] [Related]
19. FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes.
Hafner C; Di Martino E; Pitt E; Stempfl T; Tomlinson D; Hartmann A; Landthaler M; Knowles M; Vogt T
Exp Cell Res; 2010 Jul; 316(12):2008-16. PubMed ID: 20420824
[TBL] [Abstract][Full Text] [Related]
20. Epidermal nevus syndromes.
Sugarman JL
Semin Cutan Med Surg; 2007 Dec; 26(4):221-30. PubMed ID: 18395670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
